1. Blocking beta 2-adrenergic receptor inhibits dendrite ramification in a mouse model of Alzheimer's disease
- Author
-
Qin Wu, Jin-xia Sun, Xiang-he Song, Jing Wang, Cun-quan Xiong, Fei-xiang Teng, and Cui-xiang Gao
- Subjects
nerve regeneration ,neurodegeneration ,beta-2 adrenergic receptor ,Alzheimer′s disease ,amyloid-β ,ICI 118551 ,cognitive function ,dendrite ramification ,synapsin 1 ,synaptophysin ,α-secretase ,amyloid precursor protein ,neural regeneration ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Dendrite ramification affects synaptic strength and plays a crucial role in memory. Previous studies revealed a correlation between beta 2-adrenergic receptor dysfunction and Alzheimer's disease (AD), although the mechanism involved is still poorly understood. The current study investigated the potential effect of the selective β2-adrenergic receptor antagonist, ICI 118551 (ICI), on Aβ deposits and AD-related cognitive impairment. Morris water maze test results demonstrated that the performance of AD-transgenic (TG) mice treated with ICI (AD-TG/ICI) was significantly poorer compared with NaCl-treated AD-TG mice (AD-TG/NaCl), suggesting that β2-adrenergic receptor blockage by ICI might reduce the learning and memory abilities of mice. Golgi staining and immunohistochemical staining revealed that blockage of the β2-adrenergic receptor by ICI treatment decreased the number of dendritic branches, and ICI treatment in AD-TG mice decreased the expression of hippocampal synaptophysin and synapsin 1. Western blot assay results showed that the blockage of β2-adrenergic receptor increased amyloid-β accumulation by downregulating hippocampal α-secretase activity and increasing the phosphorylation of amyloid precursor protein. These findings suggest that blocking the β2-adrenergic receptor inhibits dendrite ramification of hippocampal neurons in a mouse model of AD.
- Published
- 2017
- Full Text
- View/download PDF